- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A randomized, open-label, multi-center, comparative trial, to assess the efficacy and safety of pritelivir for the treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised subjects (PRIOH-1)
This study looks at a new medicine called pritelivir for people with weakened immune systems who have cold sores or genital herpes that don’t get better with usual treatments. It wants to see if pritelivir works well and is safe.
For: Acyclovir-resistant mucocutaneous HSV infections in immunocompromised subjectsFrance · Belgium · Germany - Ongoing, recruitingTherapeutic exploratory (Phase II)
Effectiveness and Safety of Intra-Dermal Hepatitis B Vaccination after topical application of IMIQUIMOD, in cirrhotic patients, who did not respond to the conventional vaccine regimen: a pilot study
This study looks at a new way to give the Hepatitis B vaccine to people with liver scarring (cirrhosis) who haven't responded to the usual vaccine. It checks if adding a cream called Imiquimod before the vaccine helps, and if this new method is safe.
France